Ruiping Wang#, Shumei Song#, Jiangjiang Qin#, Katsuhiro Yoshimura, Fuduan Peng, Yanshuo Chu, Yuan Li, Yibo Fan, Jiankang Jin, Minghao Dang, Enyu Dai, Guangsheng Pei, Guangchun Han, Dapeng Hao, Yating Li, Deyali Chatterjee, Kazuto Harada, Melissa Pool Pizzi, Ailing W Scott, Ghia Tatlonghari, Xinmiao Yan, Zhiyuan Xu, Can Hu, Shaowei Mo, Namita Shanbhag, Yang Lu, Matheus Sewastjanow-Silva, Ahmed Adel Fouad Abdelhakeem, Guang Peng, Samir M Hanash, George A Calin, Cassian Yee, Pawel Mazur, Autumn N Marsden, Andrew Futreal, Zhenning Wang, Xiangdong Cheng, Jaffer A Ajani*, Linghua Wang*. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell. 2023 Jun 27;S1535-6108(23)00215-5. doi: 10.1016/j.ccell.2023.06.005. Online ahead of print（IF = 50.3）

Shengli Li#, Li Yuan#, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin*, Xiang-Dong Cheng*. Integrative proteomic characterization of adenocarcinoma of esophagogastric junction.  Nature Communications 2023; 14:778. https://doi.org/10.1038/s41467-023-36462-8 （IF = 17.6）

Yanshuo Chu, Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R Ingram, Krupa Thakkar, Jiang-Jiang Qin, Minghao Dang, Xiuning Le, Can Hu, Qing Deng, Ansam Sinjab, Pravesh Gupta, Ruiping Wang, Dapeng Hao, Fuduan Peng, Xinmiao Yan, Yunhe Liu, Shumei Song, Shaojun Zhang, John V Heymach, Alexandre Reuben, Yasir Y Elamin, Melissa P Pizzi, Yang Lu, Rossana Lazcano, Jian Hu, Mingyao Li, Michael Curran, Andrew Futreal, Anirban Maitra, Amir A Jazaeri, Jaffer A Ajani, Charles Swanton, Xiang-Dong Cheng, Hussein A Abbas, Maura Gillison, Krishna Bhat, Alexander J Lazar, Michael Green, Kevin Litchfield, Humam Kadara, Cassian Yee, Linghua Wang*. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nature Medicine 2023 Jun;29(6):1550-1562. doi: 10.1038/s41591-023-02371-y. （IF = 82.9）

Handong Xu #, Can Hu #, Yi Wang, Yunfu Shi, Li Yuan, Jingli Xu, Yanqiang Zhang, Jiahui Chen, Qin Wei, Jiangjiang Qin*, Zhiyuan Xu*, Xiangdong Cheng*. Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism. Oncogene Jun;42(24):1994-2006. doi: 10.1038/s41388-023-02708-4. 

Jinyun Dong*, Li Yuan, Can Hu, Xiangdong Cheng*, Jiang-Jiang Qin*. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review  Pharmacol Ther. 2023 Jul 11; 249:108488. doi: 10.1016/j.pharmthera.2023.108488. （IF = 13.5）

Xiaoqing Guan#, Jing Yang#, Weiyi Wang#*, Bing Zhao, Shiyu Hu, Dehua Yu, Li Yuan, Yunfu Shi, Jingli Xu, Jinyun Dong, Jinxin Wang, Xiang-Dong Cheng*, Jiang-Jiang Qin*. Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer.  Pharmacological Research 2023; 189:106703  https://doi.org/10.1016/j.phrs.2023.106703 （IF = 10.3）

Can Hu#, Dan Zu#, Jingli Xu#, Hangdong Xu#, Li Yuan, Jiahui Chen, Qin Wei, Yanqiang Zhang, Jing Han, Tao Lu, Jinyun Dong*, Jiang-Jiang Qin*, Zhiyuan Xu*, Xiangdong Cheng*.  Polyphyllin B Suppresses Gastric Tumor Growth By Modulating Iron Metabolism And Inducing Ferroptosis. International Journal of Biological Sciences 2023;19(4):1063-1079. doi:10.7150/ijbs.80324.（IF = 10.7）

Chunxiao Zhu#, Xiaoqing Guan#, Xinuo Zhang#, Xin Luan, Zhengbo Song, Xiang-Dong Cheng*, Weidong Zhang*, Jiang-Jiang Qin*. Targeting KRAS mutant cancers: From druggable therapy to drug resistance. Molecular Cancer 2022;21:159.   https://doi.org/10.1186/s12943-022-01629-2 （IF = 41.4）

Simin Qi#, Xiaoqing Guan#, Jia Zhang#, Dehua Yu, Xuefei Yu, Qinglin Li, Wenjuan Yin, Xiang-Dong Cheng*, Weidong Zhang*, Jiang-Jiang Qin*. Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Molecular Cancer 2022; 21:70. https://doi.org/10.1186/s12943-022-01538-4（IF = 41.4）

Jing Yang#, Lingling Wang#, Xiaoqing Guan*, Jiang-Jiang Qin*. Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: In vitro and in vivo activity and mechanisms of action. Pharmacological Research 2022; 182: 106357. https://doi.org/10.1016/j.phrs.2022.106357 （IF = 10.3）

Hao bin Li#, Jinyun Dong#,*, Mao hua Cai, Zhiyuan Xu, Xiang-Dong Cheng*, Jiang-Jiang Qin*. Protein degradation technology: A strategic paradigm shift in drug discovery.  Journal of Hematology & Oncology  2021; 14:138. DOI:  10.1186/s13045-021-01146-7.（IF = 23.1）

Libin Song#, Simin Qi#, Wei Hu#, Zhixiao Fang#, Dehua Yu, Teng Liu, Jingni Wu, Yangjun Wu, Aiwei Wu, Lanyun Feng, Jing Xie, Bo Zhang, Wenguang He, Zhouyu Ning, Luming Liu*, Jiang-Jiang Qin*, Shengli Li*. Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. Molecular Therapy-Nucleic Acids 2021; 26:11-21. Available online 2 July 2021. DOI:  10.1016/j.omtn.2021.06.015（IF = 10.1）

Li Yuan#, Shao-Wei Mo#, Zhi-Yuan Xu#, Hang Lv, Jing-Li Xu, Kai-Bo Guo, Can Hu, Xiao-Feng Wang, Gui-Ping Chen, Jiang-Jiang Qin*, Xiang-Dong Cheng*. p-MEK Expression Predicts Prognosis of Patients with Adenocarcinoma of Esophagogastric Junction (AEG) and Plays a Role in Anti-AEG Efficacy of Huaier. Pharmacological Research 2021; 165: 105411. DOI: 10.1016/j.phrs.2020.105411. （IF = 10.3）

Jinyun Dong#, Zuodong Qin#, Wei-Dong Zhang, Gang Cheng, Assaraf G Yehuda, Charles R Ashby Jr, Zhe-Sheng Chen*, Xiang-Dong Cheng*, Jiang-Jiang Qin*.  Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update.  Drug Resistance Updates  2020; 49:100681. DOI:  10.1016/j.drup.2020.100681.  (ESI 1%高被引用论文) （IF = 22.8）

Li Yuan#, Zhi-Yuan Xu#, Shan-Ming Ruan, Shaowei Mo, Jiang-Jiang Qin*, Xiang-Dong Cheng*. Long non-coding RNAs towards precision medicine in gastric cancer: Early diagnosis, treatment, and drug resistance. Molecular Cancer  2020; 19:96. DOI: 10.1186/s12943-020-01219-0. （IF = 41.4）

Jiang-Jiang Qin#,*, Yan Li#, Jia Zhang, Wei-Dong Zhang*. STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review. Journal of Experimental & Clinical Cancer Research 2019; 38(1):195. DOI: https://doi.org/10.1186/s13046-019-1206-z (ESI 1%高被引用论文) （IF = 12.6）

Wei Wang#,*, Jiang-Jiang Qin#, Sukesh Voruganti, Bhavitavya Nijampatnam, Sadanandan E Velu, Ke-He Ruan, Ming Hu, Jianwei Zhou, Ruiwen Zhang*. Discovery and characterization of dual inhibitors of MDM2 and NFAT1 for pancreatic cancer therapy. Cancer Research 2018; 78(19): 5656-5667. DOI: 10.1158/0008-5472.CAN-17-3939 （IF = 13.3）

Wei Wang, Jiang-Jiang Qin, Sukesh Voruganti, Kalkunte S Srivenugopal, Subhasree Nag, Shivaputra Patil, Horrick Sharma, Ming-Hai Wang, Hui Wang, John K Buolamwini*, Ruiwen Zhang*. The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models. Nature Communications 2014; 5: 5086. DOI: 10.1038/ncomms6086 （IF = 17.6）

Wei Wang, Jiang-Jiang Qin, Sukesh Voruganti, Ming-Hai Wang, Horrick Sharma, Shivaputra Patil, Jianwei Zhou, Hui Wang, Debabrata Mukhopadhyay, John K Buolamwini*, Ruiwen Zhang*. Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice. Gastroenterology 2014; 147(4): 893-902.e2. DOI: 10.1053/j.gastro.2014.07.001  （IF = 33.8）

Jiang-Jiang Qin#, Subhasree Nag#, Wei Wang, Jianwei Zhou, Wei-Dong Zhang, Hui Wang, Ruiwen Zhang*. NFAT as cancer target: Mission possible? Biochimica et Biophysica Acta - Reviews on Cancer 2014; 1846: 297-311. DOI: 10.1016/j.bbcan.2014.07.009 （IF = 11.4）